Aspire Biopharma to Acquire LineaPure Health
Aspire Biopharma has entered into a definitive agreement to acquire private biotech LineaPure Health. This strategic move bolsters Aspire's portfolio to address unmet needs in oncology and rare diseases.
AI-generated summary for informational purposes only. Always verify against the original filing. Not investment advice. BriefTape is not a registered investment adviser.
Get real-time financial news in your trading bot or app
GET FREE KEY — 10,000 calls/day